aluates Reports

$ 0.0

Automative

Global Injectable Osteoarthritis Microspheres Market Research Report 2025

Published Date: November 2025

Report Code: QYRE-Auto-23Q19766

BUY CHAPTERS

Global Injectable Osteoarthritis Microspheres Market Research Report 2025

Code: QYRE-Auto-23Q19766

Report

November 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merit Medical Systems

Promega Corporation

Synartro

PaciraBioSciences

Eupraxia Pharmaceuticals

Injectable Osteoarthritis Microspheres Market Size

The global market for Injectable Osteoarthritis Microspheres was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 384 million by 2031, growing at a CAGR of 13.4% during the forecast period.

Injectable Osteoarthritis Microspheres Market

Injectable osteoarthritis microspheres are innovative intra-articular drug delivery systems designed to provide localized, sustained, and controlled release of anti-inflammatory, analgesic, or cartilage-regenerative agents for the clinical management of osteoarthritis (OA). These microspheres are typically composed of biocompatible polymeric materials—such as PLGA, hyaluronic-acid–based matrices, gelatin, or natural biopolymers—capable of maintaining structural integrity within the joint cavity and releasing therapeutic agents over weeks or months. Their major advantages include reducing systemic toxicity, sustaining therapeutic concentrations locally, and improving patient compliance. With advances in regenerative medicine and drug delivery engineering, certain microspheres can also encapsulate growth factors, nucleic acid therapeutics, or antibody fragments to promote cartilage repair or regulate the inflammatory microenvironment, making them a strategic modality for precision OA therapy.The average gross profit margin of this product is 80%.

The rapid growth of the injectable osteoarthritis microsphere market is driven by accelerated population aging, rising OA prevalence, and the unique advantages of microsphere-based sustained-release systems in overcoming limitations of conventional intra-articular therapies. As clinical demand increases for long-acting efficacy and reduced injection frequency, controlled-release microspheres significantly improve treatment continuity and patient experience. Concurrent advancements in drug delivery engineering, biomaterials, and regenerative medicine further strengthen the technological foundation for innovation, while regulatory encouragement for new intra-articular therapies enhances industry confidence.

Despite strong potential, commercialization faces notable challenges. Microsphere formulations require complex manufacturing processes with strict control over particle uniformity, release kinetics, and sterile conditions. Intra-articular products encounter higher clinical risks, requiring solid evidence for safety, degradability, and local tolerability. Existing therapies such as hyaluronic acid and corticosteroid injections remain widely adopted, making market penetration dependent on clear differentiation in efficacy. Moreover, premium biomaterial costs may constrain manufacturing margins and scalability.

Downstream demand is shifting toward more precise, durable, and safer OA management solutions. Hospitals and sports medicine centers increasingly favor microsphere products offering prolonged analgesia and potential tissue-repair benefits. Patients prefer therapies with fewer injections and improved functional outcomes. With personalized medicine gaining momentum, multifunctional microspheres capable of modulating inflammation or promoting regeneration attract heightened interest. Pharmaceutical–clinic partnerships are accelerating clinical validation and translational pathways.

The upstream segment includes biodegradable polymers, biological matrices, stabilizers, crosslinking reagents, and active pharmaceutical ingredients. Materials such as PLGA, PCL, gelatin, and hyaluronic acid must meet stringent requirements for purity, molecular weight consistency, and degradation stability, directly determining microsphere formation and release performance. Supply is shared between international and regional vendors, making supply chain stability and batch consistency critical. For microspheres incorporating advanced bioactive agents, upstream materials must additionally support activity preservation and aseptic processing.

This report aims to provide a comprehensive presentation of the global market for Injectable Osteoarthritis Microspheres, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Osteoarthritis Microspheres.

The Injectable Osteoarthritis Microspheres market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Osteoarthritis Microspheres market comprehensively. Regional market sizes, concerning products by Type, by Application, by Route of Administration and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Osteoarthritis Microspheres companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Injectable Osteoarthritis Microspheres Market Report

Report Metric	Details
Report Name	Injectable Osteoarthritis Microspheres Market
Accounted market size in year	US$ 166 million
Forecasted market size in 2031	US$ 384 million
CAGR	13.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Intra-articular Joint Injection Intra-arterial Catheter Injection for GAE
Segment by Route of Administration	Non-surgical IA Injection Image-guided Catheter Embolization
Segment by Mechanism of Action	Anti-inflammatory Microspheres Analgesic Microspheres Regenerative/Cartilage-repair Microspheres
Segment by Application	Orthopedic Clinics Pain Management Clinics Hospitals Interventional Radiology Centers Ambulatory Surgery Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PaciraBioSciences, Merit Medical Systems, Eupraxia Pharmaceuticals, Promega Corporation, Synartro AB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Route of Administration etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Osteoarthritis Microspheres company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Injectable Osteoarthritis Microspheres Market growing?

Ans: The Injectable Osteoarthritis Microspheres Market witnessing a CAGR of 13.4% during the forecast period 2025-2031.

What is the Injectable Osteoarthritis Microspheres Market size in 2031?

Ans: The Injectable Osteoarthritis Microspheres Market size in 2031 will be US$ 384 million.

Who are the main players in the Injectable Osteoarthritis Microspheres Market report?

Ans: The main players in the Injectable Osteoarthritis Microspheres Market are PaciraBioSciences, Merit Medical Systems, Eupraxia Pharmaceuticals, Promega Corporation, Synartro AB

What are the Application segmentation covered in the Injectable Osteoarthritis Microspheres Market report?

Ans: The Applications covered in the Injectable Osteoarthritis Microspheres Market report are Orthopedic Clinics, Pain Management Clinics, Hospitals, Interventional Radiology Centers, Ambulatory Surgery Centers, Others

What are the Type segmentation covered in the Injectable Osteoarthritis Microspheres Market report?

Ans: The Types covered in the Injectable Osteoarthritis Microspheres Market report are Intra-articular Joint Injection, Intra-arterial Catheter Injection for GAE

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Injectable Osteoarthritis Microspheres Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intra-articular Joint Injection

1.2.3 Intra-arterial Catheter Injection for GAE

1.3 Market by Route of Administration

1.3.1 Global Injectable Osteoarthritis Microspheres Market Size Growth Rate by Route of Administration: 2020 VS 2024 VS 2031

1.3.2 Non-surgical IA Injection

1.3.3 Image-guided Catheter Embolization

1.4 Market by Mechanism of Action

1.4.1 Global Injectable Osteoarthritis Microspheres Market Size Growth Rate by Mechanism of Action: 2020 VS 2024 VS 2031

1.4.2 Anti-inflammatory Microspheres

1.4.3 Analgesic Microspheres

1.4.4 Regenerative/Cartilage-repair Microspheres

1.5 Market by Application

1.5.1 Global Injectable Osteoarthritis Microspheres Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Orthopedic Clinics

1.5.3 Pain Management Clinics

1.5.4 Hospitals

1.5.5 Interventional Radiology Centers

1.5.6 Ambulatory Surgery Centers

1.5.7 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Injectable Osteoarthritis Microspheres Market Perspective (2020-2031)

2.2 Global Injectable Osteoarthritis Microspheres Growth Trends by Region

2.2.1 Global Injectable Osteoarthritis Microspheres Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Injectable Osteoarthritis Microspheres Historic Market Size by Region (2020-2025)

2.2.3 Injectable Osteoarthritis Microspheres Forecasted Market Size by Region (2026-2031)

2.3 Injectable Osteoarthritis Microspheres Market Dynamics

2.3.1 Injectable Osteoarthritis Microspheres Industry Trends

2.3.2 Injectable Osteoarthritis Microspheres Market Drivers

2.3.3 Injectable Osteoarthritis Microspheres Market Challenges

2.3.4 Injectable Osteoarthritis Microspheres Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Injectable Osteoarthritis Microspheres Players by Revenue

3.1.1 Global Top Injectable Osteoarthritis Microspheres Players by Revenue (2020-2025)

3.1.2 Global Injectable Osteoarthritis Microspheres Revenue Market Share by Players (2020-2025)

3.2 Global Top Injectable Osteoarthritis Microspheres Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Injectable Osteoarthritis Microspheres Revenue

3.4 Global Injectable Osteoarthritis Microspheres Market Concentration Ratio

3.4.1 Global Injectable Osteoarthritis Microspheres Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Injectable Osteoarthritis Microspheres Revenue in 2024

3.5 Global Key Players of Injectable Osteoarthritis Microspheres Head office and Area Served

3.6 Global Key Players of Injectable Osteoarthritis Microspheres, Product and Application

3.7 Global Key Players of Injectable Osteoarthritis Microspheres, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Osteoarthritis Microspheres Breakdown Data by Type

4.1 Global Injectable Osteoarthritis Microspheres Historic Market Size by Type (2020-2025)

4.2 Global Injectable Osteoarthritis Microspheres Forecasted Market Size by Type (2026-2031)

5 Injectable Osteoarthritis Microspheres Breakdown Data by Application

5.1 Global Injectable Osteoarthritis Microspheres Historic Market Size by Application (2020-2025)

5.2 Global Injectable Osteoarthritis Microspheres Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Injectable Osteoarthritis Microspheres Market Size (2020-2031)

6.2 North America Injectable Osteoarthritis Microspheres Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025)

6.4 North America Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Injectable Osteoarthritis Microspheres Market Size (2020-2031)

7.2 Europe Injectable Osteoarthritis Microspheres Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025)

7.4 Europe Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Injectable Osteoarthritis Microspheres Market Size (2020-2031)

8.2 Asia-Pacific Injectable Osteoarthritis Microspheres Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Injectable Osteoarthritis Microspheres Market Size by Region (2020-2025)

8.4 Asia-Pacific Injectable Osteoarthritis Microspheres Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Injectable Osteoarthritis Microspheres Market Size (2020-2031)

9.2 Latin America Injectable Osteoarthritis Microspheres Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025)

9.4 Latin America Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Injectable Osteoarthritis Microspheres Market Size (2020-2031)

10.2 Middle East & Africa Injectable Osteoarthritis Microspheres Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025)

10.4 Middle East & Africa Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PaciraBioSciences

11.1.1 PaciraBioSciences Company Details

11.1.2 PaciraBioSciences Business Overview

11.1.3 PaciraBioSciences Injectable Osteoarthritis Microspheres Introduction

11.1.4 PaciraBioSciences Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025)

11.1.5 PaciraBioSciences Recent Development

11.2 Merit Medical Systems

11.2.1 Merit Medical Systems Company Details

11.2.2 Merit Medical Systems Business Overview

11.2.3 Merit Medical Systems Injectable Osteoarthritis Microspheres Introduction

11.2.4 Merit Medical Systems Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025)

11.2.5 Merit Medical Systems Recent Development

11.3 Eupraxia Pharmaceuticals

11.3.1 Eupraxia Pharmaceuticals Company Details

11.3.2 Eupraxia Pharmaceuticals Business Overview

11.3.3 Eupraxia Pharmaceuticals Injectable Osteoarthritis Microspheres Introduction

11.3.4 Eupraxia Pharmaceuticals Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025)

11.3.5 Eupraxia Pharmaceuticals Recent Development

11.4 Promega Corporation

11.4.1 Promega Corporation Company Details

11.4.2 Promega Corporation Business Overview

11.4.3 Promega Corporation Injectable Osteoarthritis Microspheres Introduction

11.4.4 Promega Corporation Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025)

11.4.5 Promega Corporation Recent Development

11.5 Synartro AB

11.5.1 Synartro AB Company Details

11.5.2 Synartro AB Business Overview

11.5.3 Synartro AB Injectable Osteoarthritis Microspheres Introduction

11.5.4 Synartro AB Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025)

11.5.5 Synartro AB Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merit Medical Systems

Promega Corporation

Synartro

PaciraBioSciences

Eupraxia Pharmaceuticals

List of Tables

Table 1. Global Injectable Osteoarthritis Microspheres Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intra-articular Joint Injection

Table 3. Key Players of Intra-arterial Catheter Injection for GAE

Table 4. Global Injectable Osteoarthritis Microspheres Market Size Growth Rate by Route of Administration (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Non-surgical IA Injection

Table 6. Key Players of Image-guided Catheter Embolization

Table 7. Global Injectable Osteoarthritis Microspheres Market Size Growth Rate by Mechanism of Action (US$ Million): 2020 VS 2024 VS 2031

Table 8. Key Players of Anti-inflammatory Microspheres

Table 9. Key Players of Analgesic Microspheres

Table 10. Key Players of Regenerative/Cartilage-repair Microspheres

Table 11. Global Injectable Osteoarthritis Microspheres Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 12. Global Injectable Osteoarthritis Microspheres Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 13. Global Injectable Osteoarthritis Microspheres Market Size by Region (2020-2025) & (US$ Million)

Table 14. Global Injectable Osteoarthritis Microspheres Market Share by Region (2020-2025)

Table 15. Global Injectable Osteoarthritis Microspheres Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 16. Global Injectable Osteoarthritis Microspheres Market Share by Region (2026-2031)

Table 17. Injectable Osteoarthritis Microspheres Market Trends

Table 18. Injectable Osteoarthritis Microspheres Market Drivers

Table 19. Injectable Osteoarthritis Microspheres Market Challenges

Table 20. Injectable Osteoarthritis Microspheres Market Restraints

Table 21. Global Injectable Osteoarthritis Microspheres Revenue by Players (2020-2025) & (US$ Million)

Table 22. Global Injectable Osteoarthritis Microspheres Market Share by Players (2020-2025)

Table 23. Global Top Injectable Osteoarthritis Microspheres Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Osteoarthritis Microspheres as of 2024)

Table 24. Ranking of Global Top Injectable Osteoarthritis Microspheres Companies by Revenue (US$ Million) in 2024

Table 25. Global 5 Largest Players Market Share by Injectable Osteoarthritis Microspheres Revenue (CR5 and HHI) & (2020-2025)

Table 26. Global Key Players of Injectable Osteoarthritis Microspheres, Headquarters and Area Served

Table 27. Global Key Players of Injectable Osteoarthritis Microspheres, Product and Application

Table 28. Global Key Players of Injectable Osteoarthritis Microspheres, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Injectable Osteoarthritis Microspheres Market Size by Type (2020-2025) & (US$ Million)

Table 31. Global Injectable Osteoarthritis Microspheres Revenue Market Share by Type (2020-2025)

Table 32. Global Injectable Osteoarthritis Microspheres Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 33. Global Injectable Osteoarthritis Microspheres Revenue Market Share by Type (2026-2031)

Table 34. Global Injectable Osteoarthritis Microspheres Market Size by Application (2020-2025) & (US$ Million)

Table 35. Global Injectable Osteoarthritis Microspheres Revenue Market Share by Application (2020-2025)

Table 36. Global Injectable Osteoarthritis Microspheres Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 37. Global Injectable Osteoarthritis Microspheres Revenue Market Share by Application (2026-2031)

Table 38. North America Injectable Osteoarthritis Microspheres Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. North America Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025) & (US$ Million)

Table 40. North America Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031) & (US$ Million)

Table 41. Europe Injectable Osteoarthritis Microspheres Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Europe Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025) & (US$ Million)

Table 43. Europe Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031) & (US$ Million)

Table 44. Asia-Pacific Injectable Osteoarthritis Microspheres Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 45. Asia-Pacific Injectable Osteoarthritis Microspheres Market Size by Region (2020-2025) & (US$ Million)

Table 46. Asia-Pacific Injectable Osteoarthritis Microspheres Market Size by Region (2026-2031) & (US$ Million)

Table 47. Latin America Injectable Osteoarthritis Microspheres Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Latin America Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025) & (US$ Million)

Table 49. Latin America Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031) & (US$ Million)

Table 50. Middle East & Africa Injectable Osteoarthritis Microspheres Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Middle East & Africa Injectable Osteoarthritis Microspheres Market Size by Country (2020-2025) & (US$ Million)

Table 52. Middle East & Africa Injectable Osteoarthritis Microspheres Market Size by Country (2026-2031) & (US$ Million)

Table 53. PaciraBioSciences Company Details

Table 54. PaciraBioSciences Business Overview

Table 55. PaciraBioSciences Injectable Osteoarthritis Microspheres Product

Table 56. PaciraBioSciences Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025) & (US$ Million)

Table 57. PaciraBioSciences Recent Development

Table 58. Merit Medical Systems Company Details

Table 59. Merit Medical Systems Business Overview

Table 60. Merit Medical Systems Injectable Osteoarthritis Microspheres Product

Table 61. Merit Medical Systems Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025) & (US$ Million)

Table 62. Merit Medical Systems Recent Development

Table 63. Eupraxia Pharmaceuticals Company Details

Table 64. Eupraxia Pharmaceuticals Business Overview

Table 65. Eupraxia Pharmaceuticals Injectable Osteoarthritis Microspheres Product

Table 66. Eupraxia Pharmaceuticals Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025) & (US$ Million)

Table 67. Eupraxia Pharmaceuticals Recent Development

Table 68. Promega Corporation Company Details

Table 69. Promega Corporation Business Overview

Table 70. Promega Corporation Injectable Osteoarthritis Microspheres Product

Table 71. Promega Corporation Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025) & (US$ Million)

Table 72. Promega Corporation Recent Development

Table 73. Synartro AB Company Details

Table 74. Synartro AB Business Overview

Table 75. Synartro AB Injectable Osteoarthritis Microspheres Product

Table 76. Synartro AB Revenue in Injectable Osteoarthritis Microspheres Business (2020-2025) & (US$ Million)

Table 77. Synartro AB Recent Development

Table 78. Research Programs/Design for This Report

Table 79. Key Data Information from Secondary Sources

Table 80. Key Data Information from Primary Sources

Table 81. Authors List of This Report

List of Figures

Figure 1. Injectable Osteoarthritis Microspheres Picture

Figure 2. Global Injectable Osteoarthritis Microspheres Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Injectable Osteoarthritis Microspheres Market Share by Type: 2024 VS 2031

Figure 4. Intra-articular Joint Injection Features

Figure 5. Intra-arterial Catheter Injection for GAE Features

Figure 6. Global Injectable Osteoarthritis Microspheres Market Size Comparison by Route of Administration (2020-2031) & (US$ Million)

Figure 7. Non-surgical IA Injection Features

Figure 8. Image-guided Catheter Embolization Features

Figure 9. Global Injectable Osteoarthritis Microspheres Market Size Comparison by Mechanism of Action (2020-2031) & (US$ Million)

Figure 10. Anti-inflammatory Microspheres Features

Figure 11. Analgesic Microspheres Features

Figure 12. Regenerative/Cartilage-repair Microspheres Features

Figure 13. Global Injectable Osteoarthritis Microspheres Market Size by Application (2020-2031) & (US$ Million)

Figure 14. Global Injectable Osteoarthritis Microspheres Market Share by Application: 2024 VS 2031

Figure 15. Orthopedic Clinics Case Studies

Figure 16. Pain Management Clinics Case Studies

Figure 17. Hospitals Case Studies

Figure 18. Interventional Radiology Centers Case Studies

Figure 19. Ambulatory Surgery Centers Case Studies

Figure 20. Others Case Studies

Figure 21. Injectable Osteoarthritis Microspheres Report Years Considered

Figure 22. Global Injectable Osteoarthritis Microspheres Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Injectable Osteoarthritis Microspheres Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Injectable Osteoarthritis Microspheres Market Share by Region: 2024 VS 2031

Figure 25. Global Injectable Osteoarthritis Microspheres Market Share by Players in 2024

Figure 26. Global Injectable Osteoarthritis Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Injectable Osteoarthritis Microspheres Revenue in 2024

Figure 28. North America Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Injectable Osteoarthritis Microspheres Market Share by Country (2020-2031)

Figure 30. United States Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Injectable Osteoarthritis Microspheres Market Share by Country (2020-2031)

Figure 34. Germany Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Ireland Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Injectable Osteoarthritis Microspheres Market Share by Region (2020-2031)

Figure 42. China Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia & New Zealand Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Injectable Osteoarthritis Microspheres Market Share by Country (2020-2031)

Figure 50. Mexico Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Injectable Osteoarthritis Microspheres Market Share by Country (2020-2031)

Figure 54. Israel Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Injectable Osteoarthritis Microspheres Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. PaciraBioSciences Revenue Growth Rate in Injectable Osteoarthritis Microspheres Business (2020-2025)

Figure 58. Merit Medical Systems Revenue Growth Rate in Injectable Osteoarthritis Microspheres Business (2020-2025)

Figure 59. Eupraxia Pharmaceuticals Revenue Growth Rate in Injectable Osteoarthritis Microspheres Business (2020-2025)

Figure 60. Promega Corporation Revenue Growth Rate in Injectable Osteoarthritis Microspheres Business (2020-2025)

Figure 61. Synartro AB Revenue Growth Rate in Injectable Osteoarthritis Microspheres Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions